The medicine card
What kind of treatment is being offered? Peptide treatment is a broad label. Ask for the actual medicine name and the form being discussed.
Name it before comparing it
Product What is its name? Form Tablet or injection? Purpose What is being treated? Keep the same product and form on both sides of a price comparison. Peptides contain tiny linked parts, much as a short string holds beads. Those parts are also found in proteins.
Insulin is a peptide, for example.
The word describes what the substance is made of. Ask how the exact medicine would address the health concern you brought.
Approval, custom preparation and research are different. An approved product FDA approval tells you that a finished medicine was reviewed for a particular use by the Food and Drug Administration.
Semaglutide is the medicine name in Ozempic and Wegovy products.
As of September 26, 2026, approved Ozempic uses included treating type 2 diabetes; approved Wegovy uses included weight loss.
Tirzepatide is the medicine name in Mounjaro and Zepbound products.
On that date, approved Mounjaro uses included treating type 2 diabetes; approved Zepbound uses included weight loss.
The approved uses depend on the product.
A custom preparation A doctor or pharmacy prepares a compounded medicine to meet an order.
As of September 26, 2026, FDA did not review these preparations for quality, benefit or safety before marketing.
FDA says compounding may be an option if a patient’s medical need cannot be met by an approved medicine.
A product marked for research FDA advice checked September 26, 2026, warned against weight-drug products sold for people to take while labelled “not for human consumption” or bearing the words “for research purposes.”
“Not for human consumption” means not meant for people to take.
The agency described their quality as unknown and said they could cause harm.
The category changes the questions to ask. The word peptide cannot answer them.
A generic is another specific claim. Generic means an approved version of a brand medicine.
No generic versions of semaglutide or tirzepatide had approval for marketing in the United States as of September 26, 2026.
Ask anyone using that word to identify the exact approved product.